Back to company

Core Med Tech Development ApS: Financial statements 2023

CVR: 37703788

Core Med Tech Development ApS (CVR 37703788) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -31,662 and a net result of DKK 1,222,609 compared with DKK -4,340,711 the year before. Equity amounted to DKK 15,960,654. The solvency ratio was 95.3%.

Gross Profit
-31,662 kr.
Profit/Loss
1,222,609 kr.
Equity
15,960,654 kr.
Total Assets
16,755,270 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023--32 t.1.2 mio.16 mio.-
2022--13 t.-4.3 mio.16.7 mio.-
2021--1.8 mio.36 mio.27.1 mio.-
2020--52 t.1.9 mio.16.1 mio.-
2019--8 t.7.2 mio.15.2 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

Core Med Tech Development ApS appoints new auditorOct 1, 2023

As of October 1, 2023, Grant Thornton, Godkendt Revisionspartnerselskab has been appointed auditor of Core Med Tech Development ApS.

Auditor steps down at Core Med Tech Development ApSOct 1, 2023

As of October 1, 2023, Kvist & Jensen Statsautoriseret Revisionspartnerselskab has stepped down as auditor of Core Med Tech Development ApS.

About Core Med Tech Development ApS

Core Med Tech Development ApS is a Danish company of the type Anpartsselskab based in Allerød, founded in 2016. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Steffen Vogel and Christian Schärfe Baltzer-Thomsen. The company is owned by SASSER G HOLDING ApS and Baltho Holding ApS. In 2025, the company reported a gross profit of DKK -220,933 and a net result of DKK -99,037 compared with DKK 1,645,725 the year before. Equity amounted to DKK 15,007,343.